Reports
Synthetic Biology Market Demand, Share Analysis Report, 2026-2034
REPORT DETAILS
Report Code:
PM3239
No. of Pages:
126
Format:
PDF
Published Date:
Base Year:
2025
Author:
Shreyas Shirsat
Historical Data:
2021-2024
REPORT DETAILS
Report Code:
PM3239
Published Date:
No. of Pages:
126
Historical Data:
2021-2024
Format:
PDF
Author:
Shreyas Shirsat
Base Year:
2025
ABOUT THIS REPORT
Synthetic Biology Market Size, Share, Trends, Industry Analysis Report: By Product, By Technology, By Application (Healthcare and Non-Healthcare), and By Region – Market Forecast, 2026–2034
Market Overview
The synthetic biology market size was valued at USD 18.73 billion in 2025. The market is projected to exhibit a CAGR of 17.2% from 2026 to 2034.
The market for synthetic biology encompasses the global industry focused on the design and engineering of biological systems. This includes synthetic DNA, enzymes, genome-editing tools, or organisms engineered for commercial or research applications. The market scope encompasses tools, enabling technologies, and downstream applications across healthcare, agriculture, and industrial biotechnology, among others. It excludes conventional genomics and basic molecular biology unless they are directly tied to synthetic design approaches.
From an industry analysis perspective, the factors driving market growth include the integration of gene editing, automation, artificial intelligence, and biomanufacturing. All these elements are leading to speed-up development cycles at affordable biologic costs. Emerging synthetic biology market trends in the synthetic biology industry include the integration of artificial intelligence into genetic engineering, the adoption of CRISPR applications, and the development of cell-free synthetic biology platforms.
Key Insights
- Based on product, the oligonucleotide/oligo pools & synthetic DNA segment led the global market in 2025. This is due to the growing demand for synthetic DNA and RNA across applications such as cloning and molecular diagnostics.
- By technology, the genome editing technology segment is experiencing the fastest growth. Genome editing technologies such as CRISPR-Cas9 have changed the ability to precisely modify genetic material.
- North America accounts for the largest share of the global market. The presence of a robust research infrastructure and significant investments in biotechnology contribute to the regional market dominance.
- The Europe synthetic biology market is experiencing significant growth. Supportive government policies and significant biotechnology investments drive the regional market growth.
Industry Dynamics
- Advancements in gene-editing technologies and the growing demand for bio-based products are driving growth in the market.
- The market is benefiting from rising investments in research and development from both the government and the private sector.
- The growing emphasis on bio-based alternatives is expected to present several market opportunities in the coming years.
- Ethical and biosafety concerns may present market challenges.
Market Statistics
- 2025 Market Size: USD 18.73 billion
- Synthetic Biology Market Forecast 2034: USD 78.16 billion
- CAGR (2026–2034): 17.2%
- Largest Market in 2025: North America
Market Dynamics
Advancements in Gene Editing Technologies
The synthetic biology market is driven by ongoing advances in gene-editing tools, particularly CRISPR-Cas9. From an industrial perspective, commercial applications of the CRISPR system in synthetic biology enable faster innovation and greater genetic accuracy. These applications are thus highly significant for the development of therapeutic applications, industrial enzymatic innovation, and crop improvement. The National Institutes of Health states that the use of CRISPR technology in synthetic biology has resulted in enhanced development of various treatments and innovations in agriculture, leading to an increase in demand in the market.
Increasing Demand for Bio-Based Products
There is a growing need for bio-based materials. Sectors and consumers are seeking eco-friendly alternatives to petrochemical-based materials. Synthetic biology has made it easier to develop biofuels, biodegradable plastics, and other eco-friendly materials. According to the World Economic Forum, using synthetic biology is a way to overcome challenging issues pertaining to manufacturing as well as agriculture to develop a more sustainable future for the bioeconomy.
Increasing Research and Development Investments
Massive R&D investments from the public and private sectors are driving growth in the synthetic biology market. SynBioVen invested 5.7 million dollars in SynbiCITE, a National Centre for the Industrial Translation of Synthetic Biology, among other centers in the United Kingdom, in July 2022. Such synthetic biology R&D investment boosts the development of synthetic biology solutions across diverse sectors. It also boosts innovation at the platform and commercialization levels for new technologies.
Segment Insights
Synthetic Biology Market Assessment by Product Outlook
The synthetic biology market, by product, is segmented into oligonucleotide/oligo pools & synthetic DNA, enzymes, cloning technologies kits, xeno-nucleic acids, and chassis organisms. The oligonucleotide/oligo pools & synthetic DNA accounted for the largest market share in 2025. This dominance is driven by the increasing demand for synthetic DNA and RNA, which are used in applications such as gene synthesis, cloning, and molecular diagnostics. The high adoption of these products in research and development activities across the biotechnology and pharmaceutical industries also contributes to their market position. Furthermore, improvements in DNA synthesis technologies have made the manufacturing of oligonucleotides more efficient and cost-effective, thus increasing their use.
The dominance in the synthetic DNA and oligonucleotides market stems from their relevance to gene synthesis, genome engineering, molecular diagnostics, and drug discovery. They are used as building blocks throughout the entire value chain of synthetic biology.
The enzymes segment currently represents the fastest-growing segment of the synthetic biology market. Enzymes are basically indispensable as biocatalysts in various biochemical reactions, including DNA replication, transcription, and repair. The increasing application of enzymes has been observed across diverse industries, including biotechnology for biofuels and bioplastics manufacturing, and the pharmaceutical industry for drug and diagnostic kit development. Enzyme engineering is popular because it offers better scalability and has lower production costs. Market growth is further supported by rising preference for sustainable methods across industries and the development of innovative drugs.
Synthetic Biology Market Evaluation by Technology Outlook
The market, by technology, is segmented into NGS technology, PCR technology, genome editing technology, bioprocessing technology, and other technologies. The PCR technology segment dominated the market share in 2025. Due to its widespread use in amplifying DNA sequences, PCR is indispensable across broad areas of medicine, diagnostics, food, and beverages. DNA replication allows precise replication of DNA segments, making it one of the cornerstones of life sciences. Versatility in methodology has given it a wide breadth of applications, making significant contributions to its prominent position in the market.
The genome editing technology segment is experiencing the fastest growth. Techniques like CRISPR-Cas9 have transformed the ability to perform highly accurate genetic modification. They are enabling innovative therapeutic developments, agriculture, and industrial biotechnology. The possibilities for correcting genetic defects, enhancing crop resilience, and engineering microorganisms to produce biofuels have generated significant interest and investment in genome-editing technologies. This sudden increase in applications and ongoing research efforts underscores the rapid growth and bright prospects of this genome-editing segment within synthetic biology.
Synthetic Biology Market Assessment by Application Outlook
The market, by application, is segmented into healthcare and non-healthcare. The healthcare industry accounted for the largest market share in 2025. This is due to the increased adoption of synthetic biology in gene therapies, personalized medicine, and vaccine development. Synthetic biology has made major advances in the treatment of chronic and rare diseases. This is attributed to innovations in gene editing, personal medicine, and biopharmaceuticals. With the growing need for targeted therapies and an effective drug development pipeline, major investments and research have been made in this area. Additionally, synthetic biology allows the production of customized biologics and advanced vaccines. This was evidenced during the COVID-19 pandemic. Thus, the focus on healthcare innovation and supportive regulatory environments has contributed to the segment’s leading market position.
The non-healthcare sector is showing the highest growth rate in the market. The major driver of the increasing demand is the adoption of technology across sectors such as agriculture, energy, and materials. Advancements in synthetic biology help produce biofuels, biodegradable plastics, and improved crop technologies. As organizations work to be environmentally friendly, synthetic biology applications are increasing.
Regional Outlook
By region, the study provides synthetic biology market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share of the market revenue, mainly due to its well-developed research infrastructure. The region is led by well-established companies such as Ginkgo Bioworks, headquartered in Boston, Massachusetts. The presence of major players and considerable investment has driven the growth of the synthetic biology market in the region. The region is also driven by investment from both the public and private sectors.
The market in Europe is growing rapidly, driven by strong research infrastructure and massive investments in biotechnology. In the regional frontiers, Germany, the UK, and France are leading, as many research institutions and universities are working on advanced biotechnological work. For example, Germany's focus on innovation and clean industrial processes has driven the commercialization of synthetic biology applications across several industries. Supportive government policies and funding initiatives, such as the Horizon Europe program of the European Union, further underpin research and development activities and accelerate growth within the region.
The Asia Pacific market is experiencing rapid advancements in synthetic biology, driven by rising investments in biotechnology and the need for sustainable solutions. Countries such as China, India, and Japan are promoting strategic efforts to integrate the advances of synthetic biology across industries such as agriculture, healthcare, and energy. China has seen a rise in innovation in the biotechnology product segment, including substantial investment in the precision medicine segment. Research and technological advancements in synthetic biology by academic and industry forces are fostering a robust ecosystem in the Asia Pacific market.
Key Players and Competitive Insights
The competitive dynamics in the synthetic biology market are driven by highly innovative and collaborative activities and high R&D investments. The synthetic biology market players are developing innovative solutions in gene editing, DNA synthesis, and bioengineering tools across the healthcare, agriculture, and industrial biotechnology sectors. The increased use of artificial intelligence and machine learning in synthetic biology is improving accuracy and efficiency, and thus, companies are competing in this area. Acquisitions, collaborations, and mergers in the market are helping companies develop innovative products and enter markets quickly. The sustainable, bio-based alternative is changing the market, and companies are working on synthetic biology technologies across sectors such as biopharmaceuticals, biofuels, and biodegradable plastics. Regulatory requirements, intellectual property, and ethics are proving to be highly important factors in this market. Many companies are developing technologies in this area and working to reduce costs and improve biosafety in the synthetic biology industry.
The synthetic biology market competitive landscape may be segregated into platform-based companies and product-based companies. Platform-based companies focus on cell programming, AI-driven design, and foundry services. Product-focused companies supply synthetic DNA, enzymes, and reagents. Automation, data integration, scalability, and compliance with biosecurity standards are some of the emerging differentiators of competitiveness.
Several key players in the synthetic biology market are actively advancing research across various sectors. These include Amyris, Inc.; Bruker Cellular Analysis; BICO Group AB; Codexis, Inc.; Ginkgo Bioworks Holdings, Inc.; GenScript Biotech Corporation; Integrated DNA Technologies, Inc.; Insitro, Inc.; Novozymes A/S; Pivot Bio, Inc.; Twist Bioscience Corporation; Viridos, Inc.; and Zymergen Inc. (Acquired by Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. was founded in 2008 in Boston, Massachusetts, and focuses its work on cell programming and biosecurity. The firm provides end-to-end solutions in a number of sectors: pharmaceuticals, agriculture, and industrial chemicals. Ginkgo Bioworks features a platform that can engineer custom organisms to meet specific requirements in the sectors mentioned above. Ginkgo Bioworks focuses on synthetic biology and cell programming to produce bio-based materials for the pharmaceutical, food, and agricultural sectors. Its platform uses DNA code design and debugging techniques for sustainable production and the creation of living medicines.
Twist Bioscience Corporation is a California-based firm established in 2013 with headquarters in South San Francisco. It specializes in the production of synthetic DNA. Using a silicon-based DNA synthesis technology it pioneered, Twist Bioscience develops a variety of products, including synthetic genes, next-generation sequencing tools, and antibody libraries, to serve sectors including healthcare, industrial chemicals, agriculture, and academia. Twist Bioscience Corporation applies silicon-based DNA synthesis technology to generate synthetic DNA for pharmaceutical discovery, diagnostics, and data storage. It develops long-read gene sequencing tools and antibody libraries for different sectors, including healthcare and agriculture.
List of Key Companies
- Amyris, Inc.
- Bruker Cellular Analysis
- BICO Group AB
- Codexis, Inc.
- Ginkgo Bioworks Holdings, Inc.
- GenScript Biotech Corporation
- Integrated DNA Technologies, Inc.
- Insitro, Inc.
- Novozymes A/S
- Pivot Bio, Inc.
- Twist Bioscience Corporation
- Viridos, Inc.
- Zymergen Inc. (Acquired by Ginkgo Bioworks Holdings, Inc.)
Industry Developments
September 2025: Maravai LifeSciences finalized the acquisition of Officinae Bio’s Italian DNA and RNA operations. The integration of AI-powered mRNA design with Maravai’s manufacturing strengths accelerates nucleic acid therapeutic development globally efforts.
November 2024: Ginkgo Bioworks achieved the first milestone in its collaboration with Merck to enhance biologics manufacturing. This milestone resulted in a $9 million payment to Ginkgo and marked progress in improving production efficiency and yield for biologic therapies.
August 2024: Integrated DNA Technologies enhanced its synthetic biology portfolio with the introduction of rapid genes and substantial enhancements to gene synthesis capabilities.
Market Segmentation
By Product Outlook (Revenue – USD Billion, 2021–2034)
- Oligonucleotide/Oligo Pools & Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Xeno-Nucleic Acids
- Chassis Organism
By Technology Outlook (Revenue – USD Billion, 2021–2034)
- NGS Technology
- PCR Technology
- Genome Editing Technology
- Bioprocessing Technology
- Other Technologies
By Application Outlook (Revenue – USD Billion, 2021–2034)
- Healthcare
- Non-Healthcare
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Synthetic Biology Market Report Scope
|
Report Attributes |
Details |
|
Market Size in 2025 |
USD 18.73 billion |
|
Market Size in 2026 |
USD 21.92 billion |
|
Revenue Forecast by 2034 |
USD 78.16 billion |
|
CAGR |
17.2% |
|
Base Year |
2025 |
|
Historical Data |
2021–2024 |
|
Forecast Period |
2026–2034 |
|
Quantitative Units |
Revenue in USD billion, and CAGR from 2026 to 2034 |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
Synthetic Biology Industry Trend Analysis (2025) Company profiles/industry participants profiling include company overview, financial information, product/service benchmarking, and recent developments |
|
Report Format |
PDF + Excel |
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
FAQ's
The synthetic biology market is expected to reach 78.16 billion by 2034. It is projected to account for a CAGR of 17.2% between 2026 and 2034.
Synthetic biology is used in healthcare for drug development and personalized medicine. It finds applications in agriculture for enhanced crops and industrial biotechnology for biofuels and bioplastics.
Key technologies include CRISPR gene editing, PCR technology, next-generation sequencing (NGS), and bioprocessing.
The oligonucleotide/oligo pools & synthetic DNA account for the largest market share. This is due to the increasing demand for synthetic DNA and RNA.
North America leads the synthetic biology market. This is due to significant biotechnology investments and the presence of leading market companies.
Page last updated on: May-2023
Download Sample Report of Synthetic Biology Market
Please fill out the form to request a customized copy of the research report.
